US · Healthcare

Harmony Biosciences Holdings (HRMY)

Biotechnology

Harmony Biosciences Holdings (HRMY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HRMY

P/E ratio

18.00

Harmony Biosciences Holdings (HRMY) — FAQ

What is HRMY's P/E ratio?

The price-to-earnings (P/E) ratio for Harmony Biosciences Holdings (HRMY) is 18.00 (data as of 2026-03-24).

Does Harmony Biosciences Holdings pay a dividend?

Dividend yield is not available in the current snapshot for Harmony Biosciences Holdings (HRMY). Check the MyAverix Finance app for the latest dividend data.

What sector is Harmony Biosciences Holdings in?

Harmony Biosciences Holdings (HRMY) is classified in the Healthcare sector (Biotechnology industry).

What exchange is HRMY listed on?

HRMY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)